Monthly Prescribing Reference59m
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.
Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
Pulse14m
GPs call for urgent obesity services review as demand for new drugs rises
A group of health professionals have called for a review of obesity management services in light of increased public demand ...
Everyday Health19h
Are Compounded Weight Loss Drugs on Their Way Out?
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Who Are The Best Candidates To Take Tirzepatide For Weight Loss?
Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
devdiscourse1d
Tirzepatide: A Potential Game-Changer in Tackling Long-Term Sickness
Britain is studying the use of Eli Lilly's weight loss drug, Tirzepatide, to address long-term sickness impacting its economy ...
emjreviews.com1d
Britain explores Eli Lilly’s obesity drug to tackle long-term sickness
The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people ...